Alishia Ballintine

Alishia Ballintine is a passionate patient and consumer advocate committed to advancing patient partnerships in medical development. Her advocacy is deeply personal, driven by her youngest daughter’s experience as a late preterm baby who suffered a perinatal stroke, resulting in right hemiplegic cerebral palsy and epilepsy. This experience fuels Alishia’s dedication to seeing novel regenerative therapies emerge in the field of neurodevelopmental injury. Professionally, Alishia leads consumer advisor and partnership initiatives within clinical trial research, ensuring that patient perspectives are central to the process. She is also a regulatory lawyer at a world-class clinical trial centre, where she combines her legal expertise with her commitment to see impactful research translation and drug development. Throughout her career, Alishia has gained extensive knowledge of the complex ethics and regulatory processes that shape the clinical trial lifecycle, and she advocates for increased accessibility to clinical research for all.